Recently Approved Antimicrobials for the Treatment of HABP/VABP
Information Heading link
Speaker: Keith A. Rodvold, PharmD, FCCP, FIDSA
UIC Distinguished Professor
Co-Director, Section of Infectious Diseases
Pharmacotherapy
Colleges of Pharmacy and Medicine
University of Illinois at Chicago
Session Information Heading link
ACPE UAN# 0016-0000-21-003-L01-P, 0.5 contact hour (0.05 CEUs)
0.5 AMA PRA Category 1 Credit(s)™ CME
Learning Objectives
- Describe important pharmacological characteristics
of recently approved antibiotics for the treatment of
HABP/VABP - Outline the significant features and differences
between the antibiotics used to treat Gram-negative
pathogens associated with HABP/VABP
Speaker Disclosures:
Dr. Rodvold is a speaker for Merck and Shionogi and is a consultant for the Medicine Company and VenatoRx.
Modified on January 12, 2021